In conclusion, we conducted a comprehensive evaluation of ADAR1 in pan-cancer, revealing that ADAR1 is a prognostic indicator for a variety of tumors and further exploring its implications in tumor immunity. The gene discussed is ADAR; the disease is neoplasm.